Adverse Events of HPV Vaccine Being Ignored by FDA and CDC?
Judicial Watch has attained information from the FDA under the provisions of the Freedom of Information Act on adverse events of the HPV vaccine. Included were three deaths, two of which were teens, who died from cardiac events and/or blood clots. Other adverse events included spontaneous abortions, fetal abnormalities and a significant amount neurological disorders (Bells Palsy, Guillain-Barre Syndrome, speech disorders and seizures) - some of which were determined to be permanent disabilities. The adverse events were reported in girls as young as 7 years old with a significant majority of the events being reported on girls 17 years and younger.
According Merck’s safety profile in their package insert, they stated that there was no evidence of harm to the fetus, nor was their any mention of neurological adverse events - both of which appeared repeatedly on the adverse event reports. What is probably most disturbing is the prevalence of spontaneous abortions which have occurred on the same day of the patient receiving the HPV vaccine, but the bureaucrats at the FDA and CDC fail to see, or refuse to assume a possibility of a link between the drug and fetal destruction.
FDA spokesperson Karen Riley said the agency has been monitoring adverse events associated with Gardasil but has not “seen anything at this point that would suggest we’d make any changes in the product.” John Iskander, acting director of the Immunization Safety Office at CDC, said, “None of the information I’m aware of or have seen suggests that there’s any pattern here linking birth outcomes to the vaccine.” Iskander added that pregnant women who have received the vaccine should “make sure they’re enrolled in the registry and make sure they keep up with their routine prenatal care”
Of the 18 adverse events experienced by pregnant women, 16 involved miscarriages. Richard Haupt, executive director of medical affairs for Merck, said that Gardasil likely did not cause the miscarriages (even though a majority of cases occurred just hours after the HPV injection), adding that miscarriages are common during the first three months of pregnancy. According to the Journal, one pregnant woman was found to have an abnormal fetus and another woman’s fetus was found to have an increased risk of fetal defects; however, outcomes have not been reported in the two cases.
This drug was declared safe for pregnant women based on the studies of mice, and the employee from Merck making the asinine statement which minimizes the seriousness of miscarriages by calling them “common” during the first three months of pregnancy is irrelevant to the facts. There is just cause to, at the very least, issue a product warning for pregnant women.
The burden of this dangerous immunization (which is suspiciously dissimilar to it’s FDA approval safety profile) being assumed by young girls receiving the HPV vaccine, without any evidence of the vaccine’s efficacy beyond four years is, at the very least, irresponsible - bordering on criminal. Can you imagine being the parent whose daughter died at the age of 12 after learning it was fully effective for only 4 - 6 years from a cancer of which comprises of less than 1% of the total cancer deaths in woman?
H/T LifeSite
.jpg)






































































































I’m glad I resisted the pressure by our physician to give this vaccine to my 15-year-old daughter.
Comment by Lynne — May 27, 2007 @ 9:34 pm
a cancer of which comprises of less than 1% of the total cancer deaths in woman?
Could you provide a source for that comment please.
Comment by Sharon — May 28, 2007 @ 12:20 am
The American Cancer Society estimates that 12,200 cases of cervical cancer will occur to American women this year, resulting in 4,100 deaths which represents one percent of all cancer deaths among women. Given that the HPV vaccine has been shown to protect women from only a subset of cervical cancer which makes up about 70% of the total cervical cancer cases - it potentially benefits less than 1% of the total cancer deaths among women.
Comment by shelray — May 28, 2007 @ 7:02 am